600380 健康元
2024/03 - 三个月
人民幣(K¥)
与去年同期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入4,339,814-4.81%16,646,35017,142,75315,903,68813,521,606
减:营业总成本3,296,136-7.50%13,123,51613,784,93813,169,41310,900,820
    其中:营业成本1,588,616-7.29%6,298,4666,252,2655,716,2944,874,187
               财务费用(73,645)364.30%(404,841)(352,447)(92,895)(98,886)
               资产减值损失(4,077)-321.87%(312,370)(142,628)(62,951)(80,787)
公允价值变动收益1,161-104.23%(25,420)(76,263)(23,506)10,218
投资收益20,421-48.47%79,47555,97371,881182,316
    其中:对联营企业和合营企业的投资收益18,19758.64%72,79470,57810,28117,271
营业利润1,090,5184.00%3,506,5653,479,9362,983,0672,972,955
利润总额1,086,5203.90%3,465,5553,456,1052,952,3292,950,160
减:所得税费用161,423-3.46%614,536561,797339,480371,694
净利润925,0975.30%2,851,0192,894,3082,612,8492,578,466
减:非控股权益485,29916.72%1,408,2391,391,5311,284,3501,458,027
股东净利润439,798-4.96%1,442,7801,502,7771,328,4991,120,440

市场价值指针
每股收益 (元) *0.236-1.96%0.7580.7930.6860.575
每股派息 (元) *----0.1800.1800.1500.150
每股净资产 (元) *7.62610.08%7.3746.8026.1965.682
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容